Related Experiment Video
Updated: Jun 16, 2026

10:57
Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
23.9K
Experimental human hookworm infection: a narrative historical review
Paul R Chapman1,2, Paul Giacomin3, Alex Loukas3
1Clinical Tropical Medicine, QIMR Berghofer Medical Research Institute, Herston, Australia.
Plos Neglected Tropical Diseases
|December 9, 2021
Summary
Experimental hookworm infection is safe and valuable for testing therapies and treating diseases. However, challenges remain in larval culture, storage, and accurate infection intensity measurement for research and therapeutic applications.
Area of Science:
- Parasitology
- Immunology
- Clinical Trials
Background:
- Hookworm infection research has evolved from understanding transmission to evaluating therapeutic interventions.
- Experimental human hookworm infection (EHHI) has been pivotal in elucidating infection natural history and immune responses.
Observation:
- EHHI has been safely conducted in over 500 participants, with no reported deaths and minimal serious adverse events in modern trials.
- Current methods for hookworm larval preparation and storage are outdated, hindering research and development.
- Faecal egg counts and DNA intensity lack precision for use as surrogate markers in EHHI studies.
Findings:
- EHHI is a safe and promising model for evaluating anti-hookworm therapies and investigating therapeutic potential for various diseases.
- Significant advancements are needed in in vitro larval culture, storage techniques, and the development of robust potency assays.
- Development of reliable surrogate markers for intestinal infection intensity is crucial for EHHI's utility in drug/vaccine testing and regulated therapy.
Implications:
- Standardized larval culture and storage methods are essential for reproducible EHHI research.
- Improved surrogate markers will enhance the precision of EHHI as a platform for anti-parasitic drug and vaccine development.
- EHHI holds potential for novel therapeutic applications, necessitating further methodological refinement and validation.
More Related Videos
Related Concept Videos
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...

